ReviewMetabolic brain disease2026

Repurposing apremilast for alzheimer's disease: multitarget modulation of cAMP‑PI3K/Akt-GSK‑3β and NF‑κB signaling.

Nitish Choudhary et al.PubMed ↗Publisher ↗

No numbers read from the abstract.